The late Dr. Angela H. Brodie, PhD, professor emeritus in the Department of Pharmacology at the University of Maryland School of Medicine, was honored in a special Women’s History Month Event at Westminster Hall.
Dr. Brodie pioneered the development of aromatase inhibitors, which block the production of breast cancer fueling estrogen. It is considered to be one of the greatest advances in treating breast cancer in the last 150 years.
The University of Maryland, Baltimore event was sponsored by the UMB Roundtable on Empowerment in Leadership and Leveraging Aspirations (The UMBRELLA GROUP).
The luncheon event featured a panel discussion moderated by Dr. Margaret M. McCarthy, PhD, Professor and Chair of the Department Pharmacology. Panelists included Laure Aurelian, PhD, and Yun Qiu, PhD, both of whom worked with Dr. Brodie. Also speaking was Carolyn Choate, a breast cancer survivor in long term remission, thanks to the drug developed by Dr. Brodie.
In this video, Carolyn Choate spoke about when she first contracted Dr. Brodie to thank her.
Breast Cancer Survivor Carolyn Choate
Special Video: Dr. Angela Brodie - A Pioneer in the Fight Against Breast Cancer
Please consider a gift to the Drs. Angela and Harry Brodie Distinguished Professorship in Translational Cancer Research and assure that her legacy of lifesaving discovery is continued by the next generation of scientists. The fund is close to the $2.5 million goal and you could be instrumental and helping to reach it.